Oxygen delivery to and use by primary porcine hepatocytes in the HepatAssist™ 2000 system for extracorporeal treatment of patients in end-stage liver failure

Advances in Experimental Medicine and Biology

Volumn 454, Issue , 1998, Pages 261-271

  Custer, Linda ^a   Mullon, Claudy J P ^a  

^a Circe Biomedical   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; DIAZEPAM; DISSOLVED OXYGEN; OXYGEN;

ANIMAL CELL; ARTIFICIAL LIVER; BIOREACTOR; BLOOD GAS ANALYSIS; CELL METABOLISM; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONFERENCE PAPER; DEVICE; EXTRACORPOREAL CIRCULATION; HOLLOW FIBER MEMBRANE; HUMAN; LIVER CELL; LIVER FAILURE; LIVER REGENERATION; LIVER TRANSPLANTATION; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; PRIORITY JOURNAL; SWINE;

ANIMALS; CELLS, CULTURED; EQUIPMENT DESIGN; EXTRACORPOREAL CIRCULATION; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER; LIVER, ARTIFICIAL; OXYGEN; OXYGEN CONSUMPTION; SWINE;

ANIMALIA; SUIDAE; SUS SCROFA;

EID: 0032415842     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4863-8_31     Document Type: Article

References (2)

1. Woolf G (1994) Definitions and etiology. In: Support of the acutely failing liver. Demetriou AA (ed.) Austin: RG Landes Company.
2. Watanabe FD, Mullon CJP, Hewitt WR, Arkadopoulos N, Kahaku E, Eguchi S, Khalili T, Arnaout W, Shackleton CR, Rozga J, Solomon B, Demetriou AA (1997) Clinical experience with a bioartificial liver in the treatment of severe liver failure. Ann Surg 225(5)484-94.